跳至主要内容
临床试验/ACTRN12624000076572
ACTRN12624000076572尚未招募1 期

Clindamycin and bacterial load reduction as prophylaxis for surgical site infection after below-knee flap and graft procedures in patients requiring surgical management of skin cancer below the knee: a trial protocol.

James Cook University0 个研究点目标入组 155 人开始时间: 2024年1月30日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
155

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients presenting to recruiting skin cancer clinics for surgical management of skin cancer below the knee which requires a complex surgical technique (flap or graft repair).

排除标准

  • Allergy to clindamycin, chlorhexidine or mupirocin; existing skin infection; unable to provide informed consent; peripheral vascular disease; diabetes; current use of antibiotics; clinical indication for antibiotic treatment following excision (e.g. valvular heart disease).

研究者

相似试验